Formoterol/budesonide    (DrugBank: Formoterol, Budesonide)

1 disease
IDDisease name (Link within this page)Number of trials
228Bronchiolitis obliterans1

228. Bronchiolitis obliterans    [ 92 clinical trials,   125 drugs,   (DrugBank: 34 drugs),   33 drug target genes,   152 drug target pathways]
Searched query = "Bronchiolitis obliterans", "Obliterating bronchiolitis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 92 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT00624754
(ClinicalTrials.gov)
March 200815/2/2008Prospective Evaluation of the Efficacy of Budesonide/Formoterol in Bronchiolitis Obliterans in AHSCTrecipientsProspective Evaluation of the Efficacy of Budesonide/Formoterol (Symbicort®) in Bronchiolitis Obliterans in Allogeneic Haematopoietic Stem Cell Transplantation (AHSCT) RecipientsObstructive Airway DiseaseDrug: Formoterol/Budesonide;Drug: lactoseAssistance Publique - Hôpitaux de ParisAstraZenecaCompleted16 YearsN/ABoth32Phase 2France